Jane Street’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.38M | Buy |
89,687
+23,772
| +36% | +$293K | ﹤0.01% | 5860 |
|
|
2026
Q1 | $732K | Buy |
65,915
+37,247
| +130% | +$334K | ﹤0.01% | 7176 |
|
|
2025
Q4 | $153K | Buy |
28,668
+9,135
| +47% | +$66.9K | ﹤0.01% | 9916 |
|
|
2025
Q3 | $172K | Buy |
+19,533
| New | +$172K | ﹤0.01% | 9782 |
|
|
2025
Q2 | – | Sell |
-20,740
| Closed | -$226K | – | 10210 |
|
|
2025
Q1 | $226K | Buy |
20,740
+15,272
| +279% | +$165K | ﹤0.01% | 8270 |
|
|
2024
Q4 | $54.7K | Sell |
5,468
-1,562
| -22% | -$19.7K | ﹤0.01% | 8944 |
|
|
2024
Q3 | $116K | Buy |
7,030
+3,855
| +121% | +$54.9K | ﹤0.01% | 8936 |
|
|
2024
Q2 | $35.2K | Sell |
3,175
-2,677
| -46% | -$33.3K | ﹤0.01% | 8982 |
|
|
2024
Q1 | $77.3K | Buy |
+5,852
| New | +$76K | ﹤0.01% | 8622 |
|
|
2023
Q3 | – | Sell |
-1,316
| Closed | -$33K | – | 8973 |
|
|
2023
Q2 | $33K | Buy |
+1,316
| New | +$22.1K | ﹤0.01% | 8291 |
|
|
2023
Q1 | – | Sell |
-7,150
| Closed | -$100K | – | 9439 |
|
|
2022
Q4 | $100K | Buy |
+7,150
| New | +$195K | ﹤0.01% | 8092 |
|
|
2022
Q3 | – | Sell |
-6,935
| Closed | -$241K | – | 10040 |
|
|
2022
Q2 | $241K | Buy |
6,935
+5,554
| +402% | +$356K | ﹤0.01% | 7928 |
|
|
2022
Q1 | $156K | Sell |
1,381
-1,560
| -53% | -$181K | ﹤0.01% | 9201 |
|
|
2021
Q4 | $281K | Buy |
+2,941
| New | +$265K | ﹤0.01% | 8296 |
|
|
2021
Q1 | – | Sell |
-3,197
| Closed | -$489K | – | 9340 |
|
|
2020
Q4 | $489K | Buy |
+3,197
| New | +$574K | ﹤0.01% | 5779 |
|
|
2017
Q4 | – | Sell |
-33
| Closed | -$68K | – | 4856 |
|
|
2017
Q3 | $68K | Sell |
33
-12
| -27% | -$15.7K | ﹤0.01% | 4313 |
|
|
2017
Q2 | $52K | Sell |
45
-9
| -17% | -$12K | ﹤0.01% | 4226 |
|
|
2017
Q1 | $87K | Sell |
54
-6
| -10% | -$11K | ﹤0.01% | 3983 |
|
|
2016
Q4 | $104K | Sell |
60
-9
| -13% | -$19.7K | ﹤0.01% | 3865 |
|
|
2016
Q3 | $169K | Sell |
69
-17
| -20% | -$41.9K | ﹤0.01% | 3766 |
|
|
2016
Q2 | $214K | Sell |
86
-24
| -22% | -$78.9K | ﹤0.01% | 3673 |
|
|
2016
Q1 | $398K | Sell |
110
-37
| -25% | -$129K | ﹤0.01% | 2857 |
|
|
2015
Q4 | $676K | Buy |
+147
| New | +$480K | ﹤0.01% | 2147 |
|
|
2014
Q3 | – | Sell |
-50
| Closed | -$540K | – | 2794 |
|
|
2014
Q2 | $540K | Buy |
+50
| New | +$351K | 0.01% | 1346 |
|
Other funds holding IMUX
BI
APM
B
LCM
JHC
WP
SCM
Jane Street's IMUX Position: Q2 2026 in Review
Jane Street increased its Immunic (IMUX) stake by 36% in Q2 2026, buying an estimated $293K and bringing the position to 89,687 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #5860.
Jane Street first reported a position in IMUX in Q2 2014 and has held it in 24 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.
- Jane Street held 89,687 shares of Immunic worth $1.38M as of Q2 2026.
- Jane Street bought 23,772 Immunic shares in Q2 2026, an estimated $293K.
- Immunic made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5860 holding.
- Jane Street first reported a position in Immunic in Q2 2014 and has held it in 24 quarters since.
- 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.